Compare AVTR & EICB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AVTR | EICB |
|---|---|---|
| Founded | 1904 | N/A |
| Country | United States | |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | |
| Sector | Industrials | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.5B | N/A |
| IPO Year | 2019 | N/A |
| Metric | AVTR | EICB |
|---|---|---|
| Price | $11.19 | $24.97 |
| Analyst Decision | Buy | |
| Analyst Count | 13 | 0 |
| Target Price | ★ $15.31 | N/A |
| AVG Volume (30 Days) | ★ 8.4M | N/A |
| Earning Date | 10-29-2025 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $6,575,200,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $0.17 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $10.62 | N/A |
| 52 Week High | $23.32 | N/A |
| Indicator | AVTR | EICB |
|---|---|---|
| Relative Strength Index (RSI) | 43.45 | 37.60 |
| Support Level | $10.86 | $24.95 |
| Resistance Level | $11.57 | $25.11 |
| Average True Range (ATR) | 0.35 | 0.03 |
| MACD | 0.06 | -0.00 |
| Stochastic Oscillator | 40.94 | 12.44 |
Avantor Inc provider of products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company has three geographic segments: the Americas, Europe, and AMEA. The company's product group consists of Equipment & instrumentation, Services & specialty procurement, Proprietary materials & consumables, and Third-party materials & consumables. Materials & consumables include high-purity chemicals and reagents, lab products and supplies, specialized formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, and education and microbiology and clinical trial kits, peristaltic pumps and fluid handling tips.
Eagle Point Income Co Inc is a closed-end management investment company. Its primary investment objective is to generate high current income, with a secondary objective to generate capital appreciation. The Company seeks to achieve its investment objectives by investing in junior debt tranches of collateralized loan obligations, or "CLOs," that are collateralized by a portfolio consisting of below-investment grade U.S. senior secured loans with a large number of distinct underlying borrowers across various industry sectors.